BIOMAT Database Logo BIOMAT Database Logo

A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. 1986

A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah

A number of agents that mimic the ability of the thyroid hormone, T3, to decrease plasma cholesterol levels are described; one is as effective as T3 at reducing cholesterol levels and stimulating liver function, but has very little effect on cardiac function and is thus less likely to be toxic. The agent may be useful in the treatment of atherosclerosis.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011988 Receptors, Thyroid Hormone Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively. Diiodotyrosine Receptors,Receptors, Diiodotyrosine,Receptors, Thyroxine,Receptors, Triiodothyronine,T3 Receptors,T4 Receptors,Thyroid Hormone Receptors,Thyroxine Receptors,Triiodothyronine Receptors,DIT Receptors,Diiodotyrosine Receptor,MIT Receptors,Monoiodotyrosine Receptors,Receptors, DIT,Receptors, MIT,Receptors, Monoiodotyrosine,Receptors, T3,Receptors, T4,T3 Receptor,T4 Receptor,Thyroid Hormone Receptor,Thyroxine Receptor
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Aerosolized bexarotene inhibits lung tumorigenesis without increasing plasma triglyceride and cholesterol levels in mice.
February 2011, Cancer prevention research (Philadelphia, Pa.),
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels.
April 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Increasing Thyromimetic Potency through Halogen Substitution.
November 2016, ChemMedChem,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Increasing HDL Cholesterol Levels.
April 2004, The New England journal of medicine,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients.
March 2004, Neurology,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats.
October 2000, Atherosclerosis,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Dietary cholesterol affects plasma lipid levels, the intravascular processing of lipoproteins and reverse cholesterol transport without increasing the risk for heart disease.
August 2012, Nutrients,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Lacosamide decreases neonatal seizures without increasing apoptosis.
December 2022, Epilepsia,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
[Revisit on the value of increasing plasma high-density lipoprotein cholesterol levels].
February 2017, Zhonghua xin xue guan bing za zhi,
A H Underwood, and J C Emmett, and D Ellis, and S B Flynn, and P D Leeson, and G M Benson, and R Novelli, and N J Pearce, and V P Shah
Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: influence of antioxidants.
May 1998, Research communications in molecular pathology and pharmacology,
Copied contents to your clipboard!